Tectonic Therapeutic, Inc. logo

TECX Earnings Date: Nov 5, 2026 (Estimated) — Tectonic Therapeutic, Inc.

NASDAQ · Healthcare · Biotechnology

Updated

Price $19.75
Market Cap $386.0M
P/E -4.4
52W Range $15.52 – $39.53
Next Earnings · After close (est.)

When is TECX's next earnings date?

Tectonic Therapeutic, Inc. (TECX) is expected to report Q3 2026 earnings on Thursday, November 5, 2026 at 4:00 PM ET (after market close); the date is an estimate and has not been confirmed by the company. The consensus estimate is EPS of -$1.32.

How did TECX do in its last earnings report?

In its most recent report on Aug 6, 2026 (Q2 2026), Tectonic Therapeutic, Inc. posted EPS of -$1.18 versus the -$1.35 estimate, a beat of 13.2%. Revenue was $0. The stock's 1-day post-earnings move was +2.5%.

How much does TECX stock move after earnings?

TECX beat EPS estimates in 4 of its last 8 reported quarters. Over the last 7 reports the stock moved an average of 3.9% (up or down) in the day after earnings.

About Tectonic Therapeutic, Inc.

Tectonic Therapeutic, Inc. operates as a clinical-stage biotechnology firm dedicated to the identification and progression of biologic therapies, primarily therapeutic proteins and antibodies, that regulate the function of G-protein coupled receptors (GPCRs). The company leverages its proprietary GEODe technology platform to facilitate the discovery and development of these GPCR-targeted medicines. Its robust pipeline includes an RXFP1 agonist, currently undergoing Phase 1a and 1b clinical trials for the treatment of heart failure with preserved ejection fraction. Additional programs encompass a GPCR antagonist addressing hereditary hemorrhagic telangiectasia, a bi-functional GPCR modulator aimed at fibrosis, and various other GPCR modulators. Tectonic Therapeutic, Inc. is situated in Watertown, Massachusetts.

Earnings History

DatePeriodEPS Est.EPS Act.SurpriseRevenueResult1D Δ1W Δ1M Δ
2026-08-06Q2 2026-1.35-1.18+13.24%$0✅ Beat+2.51%+12.44%+1.75%
2026-05-07Q1 2026-1.17-1.34-14.53%$0❌ Miss+7.93%+10.90%+8.30%
2026-02-26Q4 2025-1.11-1.03+7.21%$0✅ Beat-2.01%+16.38%+22.65%
2025-11-06Q3 2025-1.05-1.02+2.86%$0✅ Beat+1.74%-7.42%+5.37%
2025-03-20Q4 2024-0.92-0.84+8.70%$0✅ Beat-4.64%-14.74%-19.21%
2024-11-07Q3 2024-0.82-1.20-46.34%$0❌ Miss-3.02%-4.57%+9.44%
2024-08-14Q2 2024-1.50-4.34-189.33%$0❌ Miss+5.23%+1.18%+12.02%
2022-12-30-5.91-6.86——❌ Miss———

Showing last 8 quarters.

Related Companies

Learn More

Explore More

Financial data from licensed market-data providers; risk factors from SEC EDGAR filings. AI-powered analysis. Data last updated .